The effect of vitamin D on insulin resistance

The effect of oral vitamin D on reduction of insulin resistance in chronic kidney disease patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180114038363N1

Enrollment

Registered

2018-02-03

Start date

2018-01-21

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease. Chronic kidney disease (CKD)

Interventions

Intervention 1: Intervention group: 1000IU vitamin D tablet from Health Aid company once a day for 3 months. Intervention 2: Control group: vitamin D tablet placebo once a day for 3 months.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Chronic kidney disease stage 2-4 Age between 18-70

Exclusion criteria

Exclusion criteria: Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Insulin resistance. Timepoint: Before and after intervention. Method of measurement: Using HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Taheri

Zahedan University of Medical Sciences

elhamtaheriboroujeni@gmail.com+98 54 3329 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026